The U.S. government is taking measures to plan to distribute pfe.us's oral anti novel coronavirus drug paxlovid to testing and treatment outlets to deal with a new round of epidemic that may break out this summer's tourism season. The first new crown testing and treatment network supported by the U.S. federal government will open in Rhode Island on May 26. If the test is positive, patients can get treatment at the network on site. In the coming weeks, such outlets will gradually conduct trial operations in Massachusetts and New York City.
The government will send federal medical experts to the testing sites operated in Minnesota next week and plans to upgrade these sites to testing and treatment centers. In addition, the government has developed drug use instructions for local doctors to clarify how to manage paxlovid's interaction with other drugs. It is understood that the government has ordered 20 million courses of paxlovid. However, if the use of the drug remains high, it is expected that the drug inventory will still face the risk of shortage by this winter.
According to the U.S. Centers for Disease Control and prevention, as of May 25, the cumulative infection cases in the United States were about 83.4 million, and the average daily infection cases were about 104000.